Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SLNO
#1667
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+5.51%
Monatliche Änderung
-9.20%
6 month change
-42.34%
Jahresänderung
-13.27%
Vorheriger Schlusskurs
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
Volumen
143
Märkte
Aktien
Gesundheitswesen
SLNO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
5.31 M
5.34 M
8.17 M
32.46 M
45.86 M
51.62 M
—
Valuation ratios
Enterprise value
—
—
3.29 M
1.06 B
1.97 B
2.32 B
13.6 B
Price to earnings ratio
—
—
-0.76
-16.08
-10.26
118.72
49.49
Price to sales ratio
—
—
—
—
—
12.74
—
Price to cash flow ratio
—
—
-0.88
-25.1
-26.14
51.83
-120.95
Price to book ratio
—
—
1.78
3.97
7.37
5.39
14.46
Enterprise value to EBITDA ratio
—
—
—
—
—
267.08
—
Profitability ratios
Return on assets %
0.38
0.87
0.91
0.22
0.53
0.04
0.1
Return on equity %
0.54
1.74
2.33
0.25
0.72
0.05
0.14
Return on invested capital %
275.44
1 091.59
904.19
1 615.72
3 509.39
26.23
—
Gross margin %
—
—
—
—
—
98.58
—
Operating margin %
—
—
—
—
—
4.94
—
EBITDA margin %
—
—
—
—
—
4.56
—
Net margin %
—
—
—
—
—
10.97
—
Liquidity ratios
Quick ratio
—
—
—
—
—
5.55
—
Current ratio
5.83
2.8
2.14
14.89
15.68
5.8
56.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
0.43
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.15
0.09
—
Long term debt to total equity ratio
—
—
—
—
0.2
0.11
—
Per share metrics
Operating cash flow per share
—
—
2.48
1.51
1.72
0.89
1.02
EBIT per share
—
—
—
—
—
0.13
—
EBITDA per share
—
—
—
—
—
0.17
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.74
10.29
7.25
5.83
26.88
Net current asset value per share
—
—
1.86
10.39
7.32
6.79
29.5
Tangible book value per share
—
—
-0.04
9.02
5.93
8.5
26.95
Working capital per share
—
—
0.99
9.69
6.85
5.62
26.96
Book value per share
—
—
1.23
9.55
6.1
8.59
27.39
Nachrichten
Soleno Therapeutics stock hits 52-week low at 36.01 USD
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics übertrifft Erwartungen: Aktie legt nach starken Q4-Zahlen zu
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
Soleno Therapeutics vor Bewährungsprobe: Kennzahlen zur Markteinführung im Fokus
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics-Aktie markiert 52-Wochen-Tief bei 37,95 USD
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
Aktie von Soleno Therapeutics erreicht 52-Wochen-Tief bei 39,42 USD